Home    Company News    Silicone Rubber and Biocompatibility: Classification Standards from Short-Term Contact to Long-Term Implantation

Silicone Rubber and Biocompatibility: Classification Standards from Short-Term Contact to Long-Term Implantation

Hits: 686 img

Medical-grade silicone rubber is widely used in catheters, joint liner pads, breast implants, heart valves, and even encapsulation of deep brain stimulation electrodes. However, not all “medical silicones” are suitable for every application. International standards classify biocompatibility requirements into strict tiers based on duration of contact, anatomical location, and risk level. Understanding this classification system is essential to ensuring the safety and efficacy of medical devices—and serves as a common language among materials engineers, clinicians, and regulatory authorities.

I. ISO 10993: The Global Foundation for Biological Evaluation

The international standard ISO 10993 “Biological evaluation of medical devices” defines three main categories based on contact nature and duration:


Contact Type Duration Examples      Required Tests

Surface devices   <24 hours     Surgical gloves, face masks      Cytotoxicity, sensitization, irritation

Externally communicating devices  24 h – 30 days     Urinary catheters, respiratory masks + Acute systemic toxicity, intracutaneous reactivity

Implantable devices   >30 days      Pacemaker housings, vascular grafts      + Subchronic toxicity, genotoxicity, implantation test, hemocompatibility

Silicone rubber intended for long-term implantation (>30 days) must undergo more than 12 biological tests—a process taking 6–12 months and costing over one million RMB.

II. Material Requirements Across Application Scenarios

Short-term contact (<24 hours)

– Examples: Disposable blood collection pads, IV connector seals

– Peroxide-cured silicone may be used (lower cost)

– Focus: Control of extractables and cytotoxicity

Long-term external contact (weeks to months)

– Examples: Dialysis tubing, CPAP masks

– Must use platinum-catalyzed addition-cure silicone to avoid peroxide residues

– Requirements: Low protein adsorption, resistance to sweat-induced aging

Long-term implantation (>30 days)

– Examples: Cerebrospinal fluid shunt tubes, cochlear implant electrode encapsulants

– Must use high-purity, high-molecular-weight silicone, either unfilled or reinforced only with medical-grade fumed silica

– Platinum catalyst residue <1 ppm

– Pass implantation testing: implanted in muscle or tissue for 12 weeks; fibrous capsule thickness must be <0.5 mm

– Hemocompatibility: Hemolysis rate <5%, no platelet activation

⚠️ Note: Silicone gel used in breast implants—though a crosslinked network—is classified as “long-term implantable” due to potential rupture risks and requires additional leakage and migration studies.

III. Key Performance Indicators Explained

Cytotoxicity (ISO 10993-5): Extracts must not inhibit growth of L929 mouse fibroblasts.

Sensitization (ISO 10993-10): Guinea pig maximization test score ≤1.

Genotoxicity (ISO 10993-3): Negative results in Ames test and chromosomal aberration assay.

Implantation response (ISO 10993-6): Histology shows only mild chronic inflammation, with no necrosis or foreign-body giant cell aggregation.

IV. Regulatory Pathways: FDA and CE Requirements

U.S. FDA: Full ISO 10993 biological evaluation report required in 510(k) or PMA submissions.

EU CE Marking: Under MDR 2017/745, Class III implantable devices require notified body review of biocompatibility data.

China NMPA: Follows GB/T 16886 series (identical to ISO 10993).

V. Emerging Challenges: Beyond “Inertness” Toward Bio-Integration

Traditionally, medical silicones were expected to be “completely inert.” Recent research, however, reveals new possibilities:

Microstructured surfaces can guide organized tissue growth, reducing fibrous encapsulation;

Heparin grafting enhances hemocompatibility;

Drug-eluting formulations (e.g., dexamethasone) can modulate early immune responses.

The future of medical silicone lies in evolving from passive biocompatibility to active bio-responsiveness—achieving integration rather than isolation.

Conclusion

The “safety” of medical silicone rubber is not a vague promise—it is a precise coordinate defined by contact duration, anatomical site, and risk classification. From a fleeting touch on the skin to a decade-long presence inside the body, every material choice reflects a careful, life-centered judgment. It is this scientific, rigorous, tiered evaluation system that enables soft silicone to safely cross the boundary of skin and flesh, quietly and reliably fulfilling its mission deep within the human body—because in matters of life, the difference of a millimeter is the distance between heaven and earth.




High resilience fluorosilicone rubber MY FHTV 3270 series

Recommend

    Online QQ Service, Click here

    QQ Service

    What's App